Tag: Dermatologic Surgery

All

Long Shot: Revance’s RT002 May Banish Frown Lines for 7 Months

Revance's investigational injectable—RT002—achieves median duration of 7 months, a phase 2 active comparator study now underway.

Hot Stuff: February 2015
Xeomin Versus Botox Study for Furrows: It’s a Draw
ASDSA Launches Patient Safety Database to Gather Adverse Events During Dermatologic Surgery Procedures
Knowing Your Risk for Skin Cancer May Limit Unhealthy Behaviors

All

Sorry, No Posts Found

All

New Approach Could Help Prevent Scarring After Surgery

Researchers have discovered a naturally occurring protein that could lead to new therapies for preventing excessive scarring in patients during wound healing.

Integrating GLP-1s into Aesthetic Practice: Dr Johnny Franco on Personalizing the Patient Journey
New Revanesse Renew+ Skin-boosting Injection Debuts in Canada
Half of Americans Worry About Skin Aging, But Many Still Skip Sunscreen

Tag: Dermatologic Surgery

All

Long Shot: Revance’s RT002 May Banish Frown Lines for 7 Months

Hot Stuff: February 2015

Xeomin Versus Botox Study for Furrows: It’s a Draw

ASDSA Launches Patient Safety Database to Gather Adverse Events During Dermatologic Surgery Procedures

Knowing Your Risk for Skin Cancer May Limit Unhealthy Behaviors

All

Sorry, No Posts Found

All

New Approach Could Help Prevent Scarring After Surgery

Integrating GLP-1s into Aesthetic Practice: Dr Johnny Franco on Personalizing the Patient Journey

New Revanesse Renew+ Skin-boosting Injection Debuts in Canada

Half of Americans Worry About Skin Aging, But Many Still Skip Sunscreen

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links